Patents by Inventor AnaptysBio, Inc.

AnaptysBio, Inc. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES DIRECTED AGAINST NERVE GROWTH FACTOR (NGF)
    Publication number: 20130101601
    Abstract: The invention relates to an isolated immunoglobulin heavy chain polypeptide and an isolated immunoglobulin light chain polypeptide that binds to Nerve Growth Factor (NGF). The invention provides an NGF-binding agent that comprises the aforementioned immunoglobulin heavy chain polypeptide and immunoglobulin light chain polypeptide. The invention also provides vectors, compositions, and methods of using the NGF-binding agent to treat an NGF-mediated disease.
    Type: Application
    Filed: October 24, 2012
    Publication date: April 25, 2013
    Applicant: ANAPTYSBIO, INC.
    Inventor: AnaptysBio, Inc.
  • USE OF SOMATIC HYPERMUTATION TO CREATE INSERTION AND DELETION MUTATIONS IN VITRO
    Publication number: 20130102031
    Abstract: The invention is directed to an in vitro method for introducing one or more insertion mutations and/or one or more deletion mutations in a nucleic acid sequence encoding a polypeptide. The method comprises contacting a cell in vitro with a nucleic acid sequence, and expressing Activation Induced Cytidine Deaminase (AID) in the cell. The invention also is directed to a method of producing an immunoglobulin.
    Type: Application
    Filed: October 19, 2012
    Publication date: April 25, 2013
    Applicant: ANAPTYSBIO, INC.
    Inventor: AnaptysBio, Inc.